Evidence map›Paper›PMID 42577763›Full record

ArticleBiologics : targets & therapy2026

Bovine Milk Exosomes as Natural Cytoprotective Nanoplatforms Against Lead-Induced Toxicity.

Subhrajita Panda, Faraz Ahmad

Abstract read
In one paragraph

Article in Biologics : targets & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Subhrajita PandaDepartment of Integrative Biology, School of Bio Sciences and Technology (SBST), Vellore Institute of Technology (VIT), Vellore, TN, 632014, India.ORCID 0009-0001-6993-5918
Faraz AhmadDepartment of Integrative Biology, School of Bio Sciences and Technology (SBST), Vellore Institute of Technology (VIT), Vellore, TN, 632014, India.ORCID 0000-0003-4284-8045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Exosomes derived from mammalian milk are extracellular vesicular dietary agents capable of interspecies communication. Bovine milk exosomes (BMEs) are abundant natural nanovesicular resources that are enriched in bioactive components, including proteins, lipids, and microRNAs, and as such possess tremendous potential to affect cellular functions in the consumers. Although the applications of BMEs as delivery platforms for exogenous therapeutics are well known, their endogenous therapeutic potential remains relatively undiscerned. This study aimed to examine the cytoprotective role of BMEs as stand-alone therapeutic agents on human embryonic kidney (HEK293T) cells exposed to a prevalent environmental toxicant, lead (Pb). Methods: Isolation of BMEs was performed using standardized ultracentrifugation-based protocols. The physico-biochemical characterization of BMEs was performed using electron microscopy, Western blotting and dynamic light scattering (DLS). The ameliorative effects of BMEs were evaluated using spectrophotometric assays for cellular viability/toxicity and oxidative stress. Results: Our results confirmed that Pb is a potent cytotoxic chemical, the exposure of which was associated with significant decreases in cellular viabilities in MTT reduction and lactate dehydrogenase (LDH) release assays. Additionally, Pb treatment increased the formation of reactive oxygen (ROS) and nitrogen (RNS) species. However, cotreatment with BMEs significantly mitigated Pb-induced oxidative stress and cellular damage. Conclusion: This study highlights the endogenous potential of BMEs as therapeutic and biotechnological agents against chemical toxicity.

Indexed as

exosomesHEK293T cell lineisolation methodoxidative stressredox signalingviability

Identifiers

PMID42577763
PMCPMC13455030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.